Virtu Financial LLC Ocugen, Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.62 $73,781 - $114,361	-184,454 Reduced 83.58%	36,232 $14,000
Q2 2023 Jul 27, 2023	BUY	$0.45 - $0.88 $99,308 - $194,203	220,686 New	220,686 $120,000
Q4 2022 Feb 15, 2023	BUY	$1.11 - $1.87 $55,508 - $93,514	50,008 Added 57.38%	137,158 $178,000
Q3 2022 Nov 07, 2022	BUY	$1.75 - $3.1 $152,512 - $270,165	87,150 New	87,150 $155,000
Q1 2022 May 17, 2022	SELL	$2.34 - $4.72 $215,184 - $434,046	-91,959 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$4.38 - $15.67 $402,780 - $1.44 Million	91,959 New	91,959 $418,000
Q3 2020 Dec 11, 2020	SELL	$0.2 - $0.72 $3,075 - $11,072	-15,379 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$0.22 - $0.46 $95,399 - $199,470	-433,632 Reduced 96.57%	15,379 $3,000
Q4 2019 Feb 04, 2020	BUY	$0.27 - $2.19 $116,786 - $947,264	432,541 Added 2626.24%	449,011 $233,000
Q3 2019 Nov 20, 2019	BUY	$2.85 - $16.26 $46,939 - $267,802	16,470 New	16,470 $47,000

125

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $197M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.